Difference between revisions of "Extramammary Paget disease"

From Libre Pathology
Jump to navigation Jump to search
 
(29 intermediate revisions by one other user not shown)
Line 36: Line 36:
==General==
==General==
*Two types
*Two types
**Primary Extramammary Paget disease - a malignancy of the cutaneous apocrine glands
**Primary Extramammary Paget disease - thought to be an intraepidermal carcinoma arising from cutaneous apocrine glands
***Arises in apocrine rich areas - usually the vulva but also the groin, inguinal area, perineum, penis<ref name=pmid19126202>{{Cite journal  | last1 = Ekwueme | first1 = KC. | last2 = Zakhour | first2 = HD. | last3 = Parr | first3 = NJ. | title = Extramammary Paget's disease of the penis: a case report and review of the literature. | journal = J Med Case Reports | volume = 3 | issue =  | pages = 4 | month =  | year = 2009 | doi = 10.1186/1752-1947-3-4 | PMID = 19126202 }}</ref> or [[scrotum]].<ref name=pmid24349803>{{Cite journal  | last1 = Guerra | first1 = R. | last2 = Misra | first2 = S. | title = Management of Extramammary Paget's Disease: A Case Report and Review of the Literature. | journal = Case Rep Dermatol Med | volume = 2013 | issue =  | pages = 436390 | month =  | year = 2013 | doi = 10.1155/2013/436390 | PMID = 24349803 }}</ref> and rarely axilla or eye.
***Arises in apocrine rich areas - usually the vulva but also the groin, inguinal area, perineum, penis<ref name=pmid19126202>{{Cite journal  | last1 = Ekwueme | first1 = KC. | last2 = Zakhour | first2 = HD. | last3 = Parr | first3 = NJ. | title = Extramammary Paget's disease of the penis: a case report and review of the literature. | journal = J Med Case Reports | volume = 3 | issue =  | pages = 4 | month =  | year = 2009 | doi = 10.1186/1752-1947-3-4 | PMID = 19126202 }}</ref> or [[scrotum]] <ref name=pmid24349803>{{Cite journal  | last1 = Guerra | first1 = R. | last2 = Misra | first2 = S. | title = Management of Extramammary Paget's Disease: A Case Report and Review of the Literature. | journal = Case Rep Dermatol Med | volume = 2013 | issue =  | pages = 436390 | month =  | year = 2013 | doi = 10.1155/2013/436390 | PMID = 24349803 }}</ref> and rarely axilla or eye.
***Usually entirely intraepidermal but may be associated with an underlying apocrine gland carcinoma (in contrast to mammary Paget disease which is usually associated with underlying mammary carcinoma).
***Usually entirely intraepidermal but may rarely be associated with an underlying apocrine gland carcinoma (in contrast to mammary Paget disease which is usually associated with underlying mammary carcinoma).
**Secondary Extramammary Paget disease - intraepidermal spread from a distant tumor
**Secondary Extramammary Paget disease - intraepidermal spread from a distant tumour
***Usually of urothelial or colorectal origin.
***Usually of urothelial or colorectal origin.
***Arises in the perineal areas near these organs
***Arises in the perineal areas near these organs.
 


Clinical:
Clinical:
*Pruritis.
*Pruritis.
*R/O VIN
*R/O VIN.
*R/O vulvitis
*R/O vulvitis.


==Gross==
==Gross==
Line 77: Line 76:
<gallery>
<gallery>
Image:Anus PagetsDisease PA.JPG|Anus Pagets Disease - (SKB)
Image:Anus PagetsDisease PA.JPG|Anus Pagets Disease - (SKB)
Image:Anus PagetsDisease-2 PA.JPG|Anus Pagets Disease - Notice that the neoplastic cells ride above the normal basal cells (SKB)
Image:Anus PagetsDisease-3 PA.JPG|Anus Pagets Disease - (SKB)
Image:Anus PagetsDisease-3 PA.JPG|Anus Pagets Disease - (SKB)
Image:Anus PagetsDisease-2 PA.JPG|Anus Pagets Disease - (SKB)
Image:Penis PagetDisease MP CTR.jpg|Penis Paget Disease - medium power - (SKB)
Image:Penis PagetDisease HP CTR.jpg|Penis Paget Disease - high power - (SKB)
Image:Vulva PagetDisease LP Mater.JPG|Vulva Paget Disease  - low power - (SKB)
Image:Vulva PagetDisease MP3 Mater.JPG|Vulva Paget Disease - medium power - (SKB)
Image:Vulva PagetDisease MP Mater.JPG|Vulva Paget Disease  - medium power - (SKB)
</gallery>
</gallery>


===DDx===
===DDx===
*[[Malignant melanoma in situ]].
*[[Malignant melanoma in situ]] - atypical cells are mostly basilar with upward migration.
*[[Bowen disease]] - Pagetoid squamous cell carcinoma in situ.
<gallery>
*Pagetoid vulvar intraepithelial neoplasia
Image:Skin MMIS HP 14PY***.jpg|Melanoma in situ - notice that the atypical cells are largely down at the basal layer with some upward migration. (SKB)
*[[Vulvar squamous cell carcinoma]].
</gallery>
*Squamous cell carcinoma in situ "[[Bowen disease]]"
**Pagetoid squamous cell carcinoma in situ can look identical to extramammary Paget disease
**But should have some areas of typical SCCIS with full thickness cohesive atypia
<gallery>
Image:Skin SCCIS PagetoidandConventional 15BR30103.jpg|An SCCIS from sundamaged skin.  Pagetoid SCCIS on the left, conventional SCCIS on the right. (SKB)
</gallery>
*Pagetoid vulvar/anal/penil HPV associated intraepithelial neoplasia - Pagetoid areas often merge into areas of typical VIN
*'Paget disease' associated with an underlying local carcinoma - apocrine, Bartholin's duct etc (rare).
 
*Notice that mammary Paget disease and Toker cell hyperplasia are not part of this DDX (wrong location) except possibly in the rare case of EMPD arising in the axilla where mammary Paget disease arising from a ectopic nipple or ectopic breast tissue may be a consideration.
*Notice that EMPD is not really part of the DDX of pagetoid cutaneous squamous cell carcinoma arising on typical sun damaged skin (arm, cheek, leg) - if it's not from an apocrine rich area (and these are usually in the shade) - it's not EMPD.


==Stains==
==Stains==
Line 91: Line 106:


==IHC==
==IHC==
Panel:
*Extramammary Paget disease is a 'big' diagnosis in that the diagnosis will have significant clinical consequences. So a large panel of immuno is required to nail down the diangosis.
*CEA +ve (-ve in Bowen's disease, -ve in Toker cells).
*CK7 +ve.
**Toker cells CK7 +ve.<ref name=pmid19601945>{{Cite journal  | last1 = Nofech-Mozes | first1 = S. | last2 = Hanna | first2 = W. | title = Toker cells revisited. | journal = Breast J | volume = 15 | issue = 4 | pages = 394-8 | month =  | year =  | doi = 10.1111/j.1524-4741.2009.00743.x | PMID = 19601945 }}</ref>
*S100 -ve, HMB-45 -ve (both typically +ve in melanoma).


Additional:
*Is the lesion epithelial or melanocytic? (S100, Melan A)
*HER2/neu - usually +ve.
*Is the lesion adenocarcinoma or squamous cell carcinoma?
*CK5/6 -ve.<ref>RS. May 2010.</ref>
**Low molecular weight (CK7, cam5.2) or high molecular weight keratins (34BE12, CK5/6)?
**Usu. +ve in [[squamous cell carcinoma]].
***Don't rely entirely on the cytokeratin profile
*CAM 5.2 +ve.
***Pagetoid squamous cell carcinoma in situ can lose HMW keratins and produce a LMW profile.
**Adenocarcinoma markers? - CEA, BerEP4
**Nuclear differentiation markers? - p63 or [[p40]] (squamous) vs GATA3 (adnexal)
*Is the lesion primary or secondary?
**Secondary extramammary Paget disease may be CK20 positive (urothelial or rectal)
**Primary cutaneous extramammary Paget disease is always CK20 negative.
**If CK20 is positive are other organ specific markers positive? - CDX2 - colorectal or GATA3 - urothelial
 
Panel: You can not rely on any one marker - a panel is required
*A carcinoma marker - CEA or BerEP4 or both
*Differential keratins - low molecular weight (glandular) cam5.2, CK7 vs high molecular weight (squamous) 34BE12, CK5/6<ref>RS. May 2010.</ref>
*CK7 and CK20 - where does it come from?
*S100 and Melan A - exclude melanoma in situ
*Differentiation markers; GATA - apocrine and urothelial, p63 and p40 - squamous, CDX2 - colorectal
 
*Notice urothelial origin Paget can show immunos patterns "transitional" between glandular and squamous epithelium
**A CK20 negative urothelial origin EMPD could show a similar immunoprofile as a primary cutaneous EMPD.
*Notice that you do not need to include markers for mammary Paget disease or Toker cells.
*Do not rely on CK7 alone as CK7 may be positive in pagetoid squamous cell carcinoma in situ or extramammary Paget disease <ref>{{Cite journal  | last1 = Raju | first1 = RR. | last2 = Goldblum | first2 = JR. | last3 = Hart | first3 = WR. | title = Pagetoid squamous cell carcinoma in situ (pagetoid Bowen's disease) of the external genitalia. | journal = Int J Gynecol Pathol | volume = 22 | issue = 2 | pages = 127-35 | month = Apr | year = 2003 | doi =  | PMID = 12649666 }}</ref>
*p16 is not helpful in this DDX as  VIN, EMPD and urothelial carcioma can be positive for this marker <ref>{{Cite journal  | last1 = Sah | first1 = SP. | last2 = McCluggage | first2 = WG. | title = Florid vulval Paget disease exhibiting p16 immunoreactivity and mimicking classic VIN. | journal = Int J Gynecol Pathol | volume = 32 | issue = 2 | pages = 221-7 | month = Mar | year = 2013 | doi = 10.1097/PGP.0b013e31825909f6 | PMID = 23370646 }}</ref>
 
Roughly and with caveats........
*Primary cutaneous extramammary Paget disease -            CK7+, CK20-, BerEP4+, CEA+, S100-, MelanA-, 34BE12-, CK5/6-, p63-, GATA+, CDX2-
*Secondary extramammary Paget disease - colorectal origin - CK7-, CK20+, BerEP4+, CEA+, S100-, MelanA-, 34BE12-, CK5/6-, p63-, GATA-, CDX2+
*Secondary extramammary Paget disease - urothelial origin - CK7+, CK20+/-, BerEP4-/+, CEA-/+, S100-, MelanA-, 34BE12+, CK5/6+/-, p63+, GATA+, CDX2-
*Pagetoid VIN or squamous cell carcinoma in situ          - CK7-, CK20-, BerEP4-, CEA-, S100-, MelanA-, 34BE12+, CK5/6+ p63+, GATA-, CDX2-
*Melanoma in situ                                        - CK7-, CK20-, BerEP4-, CEA-, S100+, MelanA+, 34BE12-, CK5/6- p63-, GATA-, CDX2-
 
Sometimes it's helpful to lower the condenser when viewing this immunopanel - with a refractile background, the cell borders are highlighted and the large Paget cells stand out from the keratinocytes.
 
<gallery>
Image:Skin Vulva PagetDisease MP 15BR***.jpg|Vulva - Primary cutaneous extramammary Paget disease. (SKB)
Image:Skin Vulva PagetDisease CK7 15BR***.jpg|Vulva - Primary cutaneous extramammary Paget disease.  CK7 (SKB)
Image:Skin Vulva PagetDisease CK20 15BR***.jpg|Vulva - Primary cutaneous extramammary Paget disease.  CK20 (SKB)
Image:Skin Vulva PagetDisease 34BE12 15BR***.jpg|Vulva - Primary cutaneous extramammary Paget disease.  34BE12 the benign keratinocytes are positive (SKB)
Image:Skin Vulva PagetDisease CEA 15BR***.jpg|Vulva - Primary cutaneous extramammary Paget disease.  CEA (SKB)
Image:Skin Vulva PagetDisease GATA 15BR***.jpg|Vulva - Primary cutaneous extramammary Paget disease.  GATA3 (SKB)
Image:Skin Vulva PagetDisease p63 15BR***.jpg|Vulva - Primary cutaneous extramammary Paget disease.  p63 - the benign keratinocytes are positive (SKB)
</gallery>


==See also==
==See also==

Latest revision as of 17:15, 20 December 2016

Extramammary Paget disease
Diagnosis in short

Extramammary Paget's disease. H&E stain.
LM large epithelioid cells - nested or single - in the epidermis, clear/pale cytoplasm (occasionally eosinophilic), large nucleoli
LM DDx benign Toker cell hyperplasia, malignant melanoma, Bowen's disease, apocrine carcinoma of the skin
IHC CK7 +ve, CEA +ve, S-100 -ve, CK5/6 -ve, HER2 +ve
Gross erythema, +/-weeping, +/-crusted
Site vulva, penis, scrotum, others
Symptoms pruritis (itchy)
Prognosis typically benign - usually not associated with an underlying malignancy (unlike Paget's disease of the breast)
Clin. DDx contact dermatitis, lichen sclerosus

Extramammary Paget disease, abbreviated EMPD, is a skin disease. As the name suggests, there is also a Paget disease of the breast.

There is also a Paget disease of the bone - just to make things confusing. This is dealt with in the bone article and has nothing (from a pathologic perspective) to do with the Paget disease discussed in this article

General

  • Two types
    • Primary Extramammary Paget disease - thought to be an intraepidermal carcinoma arising from cutaneous apocrine glands
      • Arises in apocrine rich areas - usually the vulva but also the groin, inguinal area, perineum, penis[1] or scrotum [2] and rarely axilla or eye.
      • Usually entirely intraepidermal but may rarely be associated with an underlying apocrine gland carcinoma (in contrast to mammary Paget disease which is usually associated with underlying mammary carcinoma).
    • Secondary Extramammary Paget disease - intraepidermal spread from a distant tumour
      • Usually of urothelial or colorectal origin.
      • Arises in the perineal areas near these organs.

Clinical:

  • Pruritis.
  • R/O VIN.
  • R/O vulvitis.

Gross

Features:[2]

  • Plaque with an irregular border.
  • Erythematous or white.

Clinical DDx:

  • Lichen sclerosus.[3]
  • Vulvar intraepithelial neoplasia
  • Vulvar squamous cell carcinoma in situ
  • Other vulvitis

Images

Microscopic

Features:

  • Epitheliod morphology (round/ovoid).
  • Cells nested or single.
  • Classically Paget cells ride above the basal cell layer
  • But the process can fill the entire epidermis
  • Clear/pale cytoplasm key feature - may also be eosinophilic.
  • Large nucleoli.

Images

  • Anus Pagets Disease - (SKB)

  • Anus Pagets Disease - Notice that the neoplastic cells ride above the normal basal cells (SKB)

  • Anus Pagets Disease - (SKB)

  • Penis Paget Disease - medium power - (SKB)

  • Penis Paget Disease - high power - (SKB)

  • Vulva Paget Disease - low power - (SKB)

  • Vulva Paget Disease - medium power - (SKB)

  • Vulva Paget Disease - medium power - (SKB)

DDx

  • Melanoma in situ - notice that the atypical cells are largely down at the basal layer with some upward migration. (SKB)

  • Squamous cell carcinoma in situ "Bowen disease"
    • Pagetoid squamous cell carcinoma in situ can look identical to extramammary Paget disease
    • But should have some areas of typical SCCIS with full thickness cohesive atypia

  • An SCCIS from sundamaged skin. Pagetoid SCCIS on the left, conventional SCCIS on the right. (SKB)

  • Pagetoid vulvar/anal/penil HPV associated intraepithelial neoplasia - Pagetoid areas often merge into areas of typical VIN
  • 'Paget disease' associated with an underlying local carcinoma - apocrine, Bartholin's duct etc (rare).
  • Notice that mammary Paget disease and Toker cell hyperplasia are not part of this DDX (wrong location) except possibly in the rare case of EMPD arising in the axilla where mammary Paget disease arising from a ectopic nipple or ectopic breast tissue may be a consideration.
  • Notice that EMPD is not really part of the DDX of pagetoid cutaneous squamous cell carcinoma arising on typical sun damaged skin (arm, cheek, leg) - if it's not from an apocrine rich area (and these are usually in the shade) - it's not EMPD.

Stains

IHC

  • Extramammary Paget disease is a 'big' diagnosis in that the diagnosis will have significant clinical consequences. So a large panel of immuno is required to nail down the diangosis.
  • Is the lesion epithelial or melanocytic? (S100, Melan A)
  • Is the lesion adenocarcinoma or squamous cell carcinoma?
    • Low molecular weight (CK7, cam5.2) or high molecular weight keratins (34BE12, CK5/6)?
      • Don't rely entirely on the cytokeratin profile
      • Pagetoid squamous cell carcinoma in situ can lose HMW keratins and produce a LMW profile.
    • Adenocarcinoma markers? - CEA, BerEP4
    • Nuclear differentiation markers? - p63 or p40 (squamous) vs GATA3 (adnexal)
  • Is the lesion primary or secondary?
    • Secondary extramammary Paget disease may be CK20 positive (urothelial or rectal)
    • Primary cutaneous extramammary Paget disease is always CK20 negative.
    • If CK20 is positive are other organ specific markers positive? - CDX2 - colorectal or GATA3 - urothelial

Panel: You can not rely on any one marker - a panel is required

  • A carcinoma marker - CEA or BerEP4 or both
  • Differential keratins - low molecular weight (glandular) cam5.2, CK7 vs high molecular weight (squamous) 34BE12, CK5/6[4]
  • CK7 and CK20 - where does it come from?
  • S100 and Melan A - exclude melanoma in situ
  • Differentiation markers; GATA - apocrine and urothelial, p63 and p40 - squamous, CDX2 - colorectal
  • Notice urothelial origin Paget can show immunos patterns "transitional" between glandular and squamous epithelium
    • A CK20 negative urothelial origin EMPD could show a similar immunoprofile as a primary cutaneous EMPD.
  • Notice that you do not need to include markers for mammary Paget disease or Toker cells.
  • Do not rely on CK7 alone as CK7 may be positive in pagetoid squamous cell carcinoma in situ or extramammary Paget disease [5]
  • p16 is not helpful in this DDX as VIN, EMPD and urothelial carcioma can be positive for this marker [6]

Roughly and with caveats........

  • Primary cutaneous extramammary Paget disease - CK7+, CK20-, BerEP4+, CEA+, S100-, MelanA-, 34BE12-, CK5/6-, p63-, GATA+, CDX2-
  • Secondary extramammary Paget disease - colorectal origin - CK7-, CK20+, BerEP4+, CEA+, S100-, MelanA-, 34BE12-, CK5/6-, p63-, GATA-, CDX2+
  • Secondary extramammary Paget disease - urothelial origin - CK7+, CK20+/-, BerEP4-/+, CEA-/+, S100-, MelanA-, 34BE12+, CK5/6+/-, p63+, GATA+, CDX2-
  • Pagetoid VIN or squamous cell carcinoma in situ - CK7-, CK20-, BerEP4-, CEA-, S100-, MelanA-, 34BE12+, CK5/6+ p63+, GATA-, CDX2-
  • Melanoma in situ - CK7-, CK20-, BerEP4-, CEA-, S100+, MelanA+, 34BE12-, CK5/6- p63-, GATA-, CDX2-

Sometimes it's helpful to lower the condenser when viewing this immunopanel - with a refractile background, the cell borders are highlighted and the large Paget cells stand out from the keratinocytes.

  • Vulva - Primary cutaneous extramammary Paget disease. (SKB)

  • Vulva - Primary cutaneous extramammary Paget disease. CK7 (SKB)

  • Vulva - Primary cutaneous extramammary Paget disease. CK20 (SKB)

  • Vulva - Primary cutaneous extramammary Paget disease. 34BE12 the benign keratinocytes are positive (SKB)

  • Vulva - Primary cutaneous extramammary Paget disease. CEA (SKB)

  • Vulva - Primary cutaneous extramammary Paget disease. GATA3 (SKB)

  • Vulva - Primary cutaneous extramammary Paget disease. p63 - the benign keratinocytes are positive (SKB)

See also

References

  1. ↑ Ekwueme, KC.; Zakhour, HD.; Parr, NJ. (2009). "Extramammary Paget's disease of the penis: a case report and review of the literature.". J Med Case Reports 3: 4. doi:10.1186/1752-1947-3-4. PMID 19126202.
  2. ↑ 2.0 2.1 2.2 Guerra, R.; Misra, S. (2013). "Management of Extramammary Paget's Disease: A Case Report and Review of the Literature.". Case Rep Dermatol Med 2013: 436390. doi:10.1155/2013/436390. PMID 24349803.
  3. ↑ Bansal, D.; Bowman, CA. (Feb 2004). "Extramammary Paget's disease masquerading as lichen sclerosus.". Int J STD AIDS 15 (2): 141-2. doi:10.1258/095646204322764361. PMID 15006079.
  4. ↑ RS. May 2010.
  5. ↑ Raju, RR.; Goldblum, JR.; Hart, WR. (Apr 2003). "Pagetoid squamous cell carcinoma in situ (pagetoid Bowen's disease) of the external genitalia.". Int J Gynecol Pathol 22 (2): 127-35. PMID 12649666.
  6. ↑ Sah, SP.; McCluggage, WG. (Mar 2013). "Florid vulval Paget disease exhibiting p16 immunoreactivity and mimicking classic VIN.". Int J Gynecol Pathol 32 (2): 221-7. doi:10.1097/PGP.0b013e31825909f6. PMID 23370646.
Retrieved from "https://librepathology.org/w/index.php?title=Extramammary_Paget_disease&oldid=46516"